Butorphanol tartrate is a synthetic opioid analgesic classified as a kappa-receptor agonist and mu-receptor antagonist (agonist-antagonist opioid). It is one of the most commonly used opioids in equine, canine, and feline veterinary medicine. In horses, butorphanol is most often used as a sedation adjunct in combination with alpha-2 agonists (xylazine or detomidine) for standing procedures. In dogs and cats, it is used for acute pain management, pre-anesthetic sedation, and antitussive (cough suppression) purposes.
Overview
Butorphanol provides moderate analgesia primarily through kappa-opioid receptor activation. Its mu-receptor antagonism gives it a ceiling effect for analgesia (increasing the dose beyond a certain point does not increase pain relief) and a somewhat lower risk of respiratory depression compared to pure mu-agonist opioids like morphine. In horses, butorphanol alone can cause CNS excitation (increased locomotion); therefore, it is almost always used in combination with a sedative such as an alpha-2 agonist.
Uses
Horses:
- Sedation adjunct — combined with xylazine or detomidine for enhanced sedation and analgesia during standing procedures
- Colic analgesia — short-term visceral pain relief, often combined with xylazine
- Pre-anesthetic medication — part of multi-drug sedation/anesthesia protocols
- Post-operative pain management — short-term use
Dogs:
- Acute pain management — moderate pain from surgery, trauma, or medical conditions
- Pre-anesthetic sedation — commonly combined with acepromazine or dexmedetomidine
- Antitussive (cough suppression) — effective cough suppressant
Cats:
- Acute pain management — post-surgical and traumatic pain
- Pre-anesthetic sedation — commonly used in feline sedation protocols
- Sedation for minor procedures — combined with other agents
Dosage
Administered by or under the direction of a veterinarian.
| Species | Dose | Route | Frequency | Notes |
|---|---|---|---|---|
| Horses | 0.01-0.04 mg/kg | IV or IM | Every 2-4 hours as needed | Almost always combined with alpha-2 agonist |
| Dogs | 0.2-0.4 mg/kg | IV, IM, or SQ | Every 2-4 hours | Also available as oral tablets (Torbutrol) for cough |
| Cats | 0.2-0.4 mg/kg | IV, IM, or SQ | Every 4-6 hours | Well tolerated in cats |
In horses: The most common protocol combines butorphanol 0.01-0.02 mg/kg IV with xylazine 0.5-1.0 mg/kg IV or detomidine 0.01-0.02 mg/kg IV. This combination provides superior sedation and analgesia compared to either drug alone, with synergistic effects that allow lower individual doses.
Duration of action is relatively short (2-4 hours for analgesia in most species), which is useful for short procedures but may require repeat dosing or transition to other analgesics for sustained pain management.
Side Effects
Horses:
| Common | Serious |
|---|---|
| Mild sedation (when combined with alpha-2 agonist) | CNS excitation if given alone (increased locomotion, agitation) |
| Decreased GI motility | Respiratory depression (rare at clinical doses) |
| Occasional lip or head movements |
Dogs and Cats:
| Common | Serious |
|---|---|
| Sedation | Respiratory depression (rare at clinical doses) |
| Mild nausea/salivation | Bradycardia |
| Decreased appetite (transient) | Excessive sedation |
| Panting (dogs) |
The ceiling effect on analgesia means that butorphanol is best suited for mild to moderate pain. For severe pain (e.g., major orthopedic surgery, severe trauma), pure mu-agonist opioids or multimodal analgesic protocols may be more appropriate.
Drug Interactions
- Alpha-2 agonists (xylazine, detomidine, dexmedetomidine): Synergistic sedation and analgesia. This is the most common and intended combination.
- Other CNS depressants (acepromazine, benzodiazepines, general anesthetics): Additive sedation and respiratory depression; dose adjustments required.
- Pure mu-agonist opioids (morphine, hydromorphone, fentanyl): Butorphanol’s mu-antagonism may partially reverse the analgesic effects of pure mu-agonists. Do not combine without veterinary direction.
- Phenothiazine tranquilizers (acepromazine): Commonly combined in small animal protocols; additive sedation.
Contraindications
- Known hypersensitivity to butorphanol
- Horses: avoid using butorphanol alone without a sedative (risk of CNS excitation)
- Severe respiratory compromise (any species)
- Animals currently receiving pure mu-agonist opioids (may antagonize their analgesic effect)
- Use with caution in animals with liver disease (hepatic metabolism)
- Use with caution in animals with head trauma (opioids may affect intracranial pressure assessment)
Storage
- Store at controlled room temperature, 59-86 degrees F (15-30 degrees C).
- Protect from light.
- Keep in a locked cabinet (Schedule IV controlled substance in the United States).
- Keep out of reach of children.
Frequently Asked Questions
Why is butorphanol almost always combined with xylazine or detomidine in horses? Opioids can cause CNS excitation in horses when used alone, manifesting as increased locomotion and restlessness. Combining butorphanol with an alpha-2 agonist sedative prevents this excitation and produces synergistic sedation and analgesia that is superior to either drug alone.
Is butorphanol strong enough for severe pain? Butorphanol has a ceiling effect on analgesia and is best for mild to moderate pain. For severe pain (major surgery, fractures, severe colic), your veterinarian may choose a pure mu-agonist opioid or a multimodal pain management approach.
How long does butorphanol last? Analgesic duration is approximately 2-4 hours in most species. This short duration makes it useful for procedures but may require repeat dosing for sustained pain relief.
Is butorphanol safe for cats? Yes. Butorphanol is well tolerated in cats and is one of the most commonly used opioids in feline medicine. It provides reliable sedation and moderate analgesia.
This information is for educational purposes only and does not replace professional veterinary advice. Always consult your veterinarian before administering any medication to your animal.